Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction.

BACKGROUND Little is known about the prognostic significance of elevated serum heart-type fatty acid-binding protein (H-FABP) in post-acute myocardial infarction (post-AMI) patients. METHODS AND RESULTS A total of 1,283 post-AMI patients with available serum samples collected in the convalescent stage were studied. During a median follow-up period of 1,785 days, 176 patients (14%) had adverse events (all-cause mortality, n=81; non-fatal MI, n=44; readmission for heart failure [HF], n=51). Patients were divided into 2 groups according to a serum H-FABP level of 6.08ng/ml, which was determined to be the optimal cut-off for discriminating all-cause mortality based on the maximum value of the area under the receiver operating characteristic curve. Patients with elevated H-FABP (>6.08ng/ml, n=224) had a significantly higher incidence of death (18.3% vs. 3.8%, P<0.001) and readmission for HF (10.3% vs. 2.6%, P<0.001), but not of non-fatal MI (4.5% vs. 3.2%, P=0.187), compared to those with H-FABP <6.08ng/ml. Multivariate Cox regression analysis indicated that elevated serum H-FABP was associated with an increased risk of mortality (hazard ratio [HR], 1.91; 95% confidence interval [CI]: 1.03-3.51, P=0.039) and readmission for HF (HR, 2.49; 95% CI: 1.15-5.39, P=0.020). CONCLUSIONS Elevated serum H-FABP during the convalescent stage of AMI predicted long-term mortality and readmission for HF after survival discharge in the post-AMI patients.

[1]  A. Hall,et al.  Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. , 2010, Journal of the American College of Cardiology.

[2]  T. Delibaşı,et al.  Serum heart type fatty acid binding protein levels in metabolic syndrome , 2009, Endocrine.

[3]  M. Hori,et al.  Impact of diabetes mellitus on rehospitalization for heart failure among survivors of acute myocardial infarction in the percutaneous coronary intervention era. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[4]  A. Hall,et al.  Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. , 2007, Journal of the American College of Cardiology.

[5]  M. Plebani,et al.  Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. , 2007, Clinical biochemistry.

[6]  P. Coriat,et al.  Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. , 2007, International journal of cardiology.

[7]  M. Hori,et al.  Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. , 2007, The American journal of cardiology.

[8]  I. Kubota,et al.  Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. , 2007, Journal of cardiac failure.

[9]  M. Sabatine,et al.  Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes , 2006, Circulation.

[10]  T. Takano,et al.  Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/Fas ligand system. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[11]  M. Hori,et al.  Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[12]  T. Takano,et al.  Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[13]  T. Takano,et al.  Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. , 2002, The American journal of medicine.

[14]  S. Kristensen,et al.  Biochemical Markers of Ischaemia for the Early Identification of Acute Myocardial Infarction without ST Segment Elevation , 2001, Cardiology.

[15]  K. Kawamura,et al.  Human Heart-Type Cytoplasmic Fatty Acid-Binding Protein (H-FABP) for the Diagnosis of Acute Myocardial Infarction. Clinical Evaluation of H-FABP in Comparison with Myoglobin and Creatine Kinase Isoenzyme MB , 2000, Clinical chemistry and laboratory medicine.

[16]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[17]  J. Glatz,et al.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man , 1992, Molecular and Cellular Biochemistry.

[18]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[19]  J. Veerkamp,et al.  Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. , 1991, Biochimica et biophysica acta.

[20]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[21]  W. Kannel,et al.  The natural history of congestive heart failure: the Framingham study. , 1971, The New England journal of medicine.

[22]  I. Takeuchi,et al.  Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarction. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[23]  I. Komuro,et al.  Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. , 2012, Journal of cardiology.

[24]  I. Komuro,et al.  Longitudinal risk of cardiovascular events in relation to depression symptoms after discharge among survivors of myocardial infarction. Osaka Acute Coronary Insufficiency Study. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[25]  Kenji Inoue,et al.  Heart fatty acid-binding protein offers similar diagnostic performance to high-sensitivity troponin T in emergency room patients presenting with chest pain. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[26]  M. Cheitlin.  Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular Death , 2010 .

[27]  W. Hermens,et al.  Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. , 1997, Clinical chemistry.